Reannon Pharmaceuticals Limited Liability Partnership - Company Profile

It is a electrnoics limited liability partnership based in Navi Mumbai, Maharashtra, India, established in 2013.

2013 Navi Mumbai, Maharashtra, India Struck Off

Last Updated: July 24, 2025

About Reannon Pharmaceuticals Limited Liability Partnership

Reannon Pharmaceuticals Limited Liability Partnership, a struck off limited liability partnership, was established on 20 June 2013 in Navi Mumbai, Maharashtra, India. Engaging in manufacturing within the electrnoics sector, it holds LLPIN: AAB-5979. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.50 M.

Its leadership includes Shobha Gole Bhimrao (Designated Partner), Bhimrao Haribhau Gole (Designated Partner). It is based at Shop No. 8, Matruchaaya, Plot No. 57 Sector 8-A, Airoli, Navi Mumbai, Maharashtra, 400708.

Company Details

CIN/LLPIN
AAB-5979
Incorporation Date
20 June 2013
Total Obligation of Contribution
₹0.50 M
ROC Code
Roc Mumbai
Company Status
Struck Off

Key Metrics

Obligation of Contribution ₹ 0.50 M as on 24-07-2025
Company Age 12 Year, 8 Months

Comprehensive Company Insights

Explore comprehensive insights into Reannon Pharmaceuticals Limited Liability Partnership — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Reannon Pharmaceuticals Limited Liability Partnership?

Current Designated Partners

Name	Designation	Appointment Date	Status
Shobha Gole Bhimrao	Designated Partner	20 Jun 2013	Current
Bhimrao Haribhau Gole	Designated Partner	20 Jun 2013	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Reannon PharmaceuticalsLiability Partnership.

Enhance accessibility to Reannon PharmaceuticalsLiability Partnership's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Reannon PharmaceuticalsLiability Partnership?

Unlock access to Reannon PharmaceuticalsLiability Partnership's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Reannon PharmaceuticalsLiability Partnership?

Unlock and access historical data on people associated with Reannon PharmaceuticalsLiability Partnership, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Reannon PharmaceuticalsLiability Partnership, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reannon PharmaceuticalsLiability Partnership's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Reannon PharmaceuticalsLiability Partnership

Recent Activity within the Organization

Director Appointment

Progress on Shobha Gole Bhimrao was appointed as a Designated Partner was appointed as a Designated Partner on 20 Jun 2013 & has been associated with this company since 12 years 8 months . was documented.
20 Jun 2013
Director Appointment

The activity Bhimrao Haribhau Gole was appointed as a Designated Partner was appointed as a Designated Partner on 20 Jun 2013 & has been associated with this company since 12 years 8 months . was completed.
20 Jun 2013
LLP Incorporation

Progress on Reannon Pharmaceuticals Limited Liability Partnership was registered on 20 Jun 2013 with Roc Mumbai & aged 12 years 8 months as per MCA records. was documented.
20 Jun 2013

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the LLPIN of Reannon Pharmaceuticals Limited Liability Partnership?

The LLPIN of Reannon Pharmaceuticals Limited Liability Partnership is AAB-5979.

Where is Reannon Pharmaceuticals Limited Liability Partnership headquartered?

Reannon Pharmaceuticals Limited Liability Partnership is headquartered at Shop No. 8, Matruchaaya, Plot No. 57 Sector 8-A, Airoli, Navi Mumbai, Maharashtra, 400708.

When was Reannon Pharmaceuticals Limited Liability Partnership incorporated?

Reannon Pharmaceuticals Limited Liability Partnership was incorporated on 20 June 2013.

Who are the current directors of Reannon Pharmaceuticals Limited Liability Partnership?

The current directors of Reannon Pharmaceuticals Limited Liability Partnership are

What is the primary industry of Reannon Pharmaceuticals Limited Liability Partnership?

The primary industry of Reannon Pharmaceuticals Limited Liability Partnership is Electrnoics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available